AIMC Topic: Antineoplastic Agents, Hormonal

Clear Filters Showing 11 to 12 of 12 articles

Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure.

Journal of the National Cancer Institute Dec 1, 2017
BACKGROUND: Aromatase inhibitors (AIs) are given as adjuvant therapy for hormone receptor-positive breast cancer in postmenopausal women, also to those with chemotherapy-induced ovarian function failure. The current analysis reports on endocrine data...
Humans Prognosis Female Adult Breast Neoplasms Middle Aged Case-Control Studies Estradiol Recovery of Function Randomized Controlled Trials as Topic Aromatase Inhibitors Anastrozole Antineoplastic Agents, Hormonal Chemotherapy, Adjuvant Clinical Trials, Phase III as Topic Ovarian Diseases Ovary Tamoxifen
View on PubMed DOI

Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors.

Acta reumatologica portuguesa Jan 1, 2015
Breast cancer is the most commonly diagnosed cancer among women, but despite survival rates improvement, it is still the second major cause of cancer related death. In postmenopausal women with estrogen receptor (ER) dependent breast cancer, hormone ...
Humans Female Breast Neoplasms Neoplasm Recurrence, Local Bone Density Conservation Agents Postmenopause Aromatase Inhibitors Receptors, Estrogen Fractures, Spontaneous Antineoplastic Agents, Hormonal Tamoxifen Osteoporosis, Postmenopausal
View on PubMed
Popular Topics
Recent Journals